Overview

EpiTrace.AI — Epigenomic Intelligence for Researchers, Clinicians & Innovators

EpiTrace.AI is a next-generation platform for decoding single-cell methylation patterns, reconstructing clonal lineages, and generating actionable intelligence across development, disease, and aging.

It unifies analytics, AI, lineage reconstruction, CpG biomarker discovery, and multi-modal visualization into a single scientific interface — designed for research teams, clinicians, consortia, and translational programs.

01 — Challenge

The Fragmentation Problem in Epigenomics & Life Data

Despite progress in genomics and health AI, the true life story of each cell remains fragmented and scattered across tools, institutes, cohorts, and environments.

Key challenges EpiTrace.AI addresses:

EpiTrace.AI solves this by offering an integrated, explainable, trusted platform for lineage intelligence and epigenetic pattern discovery.

02 — Vision

From Dashboard to Global Life & Disease Atlas

Our vision is to create the world’s trusted platform for decoding the life story of every cell:

The current v9.4.3 platform is the foundation for this global vision — evolving toward a cloud-native, collaborative biomedical intelligence system.

03 — Differentiators

What Makes EpiTrace.AI Unique

  • Life Story Intelligence — Focus on temporal trajectories, not snapshots.
  • Explainable by Design — Transparent models, interpretable results.
  • FAIR++ Data Philosophy — Mapped, annotated, shareable multi-omics.
  • Modular SuperUI — UMAP Viewer, Lineage Explorer, CpG Explorer, Export.
  • Partner-driven Development — DKFZ, Rurainski Foundation, ETHORITY.
  • Scalable Roadmap — Ready for AI transformers, cross-cohort integration.
04 — Use Cases

From Bench to Bedside to Global Health

Research & Academia

  • Epigenetic switch discovery
  • Lineage tracing of tumors & organoids
  • Multi-omics integration for systems biology
  • Automated CpG biomarker ranking

Clinical & Translational Medicine

  • Precision diagnostics & early detection
  • Minimal Residual Disease (MRD) monitoring
  • Therapy-response analysis using methylation states
  • Interactive digital tumor boards

Pharma & Biotech

  • Biomarker validation & companion diagnostics
  • Target discovery from epigenomic landscapes
  • Clinical trial cohort stratification
  • Virtual response modeling (future roadmap)

Public Health & Advocacy

  • Population-level epigenetic risk mapping
  • Citizen science under ethical governance
  • Early detection initiatives ↔ research synergy
05 — Case Study

EpiTrace.AI — A Compass for the Biology of Healing

EpiTrace.AI enables researchers to trace epigenetic life stories encoded in cells, revealing clonal development, disease evolution, and regenerative potential.

Future trajectory: Gene Regulation Atlas, longitudinal patient integration, multi-species prediction models.

06 — DKFZ Collaboration

Partnerships with DKFZ & the Dr. Rurainski Foundation

EpiTrace.AI is co-developed with leading researchers at the German Cancer Research Center (DKFZ) and supported by the Dr. Rurainski Foundation. Areas of collaboration:

07 — Architecture

Technical Architecture — Version 9.4.3

EpiTrace.AI operates on a secure, hardened cloud environment engineered for scientific reliability, transparent analytics, and long-term extensibility. The platform is optimized for single-cell methylation workflows while remaining ready for multi-omics expansion.

Core Stack

Infrastructure

Security & Stability

The architecture remains intentionally lean to ensure stability, while providing a strong foundation for the next-generation evolution of EpiTrace.AI.

Scalability Roadmap

08 — Access & Collaboration

Research Partners, Foundations, Clinics

EpiTrace.AI is currently available as a research-grade PoC with active partner programs.

Contact: sten@ethority.ai